openPR Logo
Press release

Hope for a new possibility of therapy for children suffering from heart insufficiency in Poland - First EXCOR® Pediatric implantations successful

06-01-2011 07:18 AM CET | Health & Medicine

Press release from: Berlin Heart

Hope for a new possibility of therapy for children suffering from

Newborns with heart failure or children suffering from severe heart insufficiency in Poland don’t really have much of a choice. A heart transplant most of the time is the only survival possibility. The problem the Polish doctors are facing, is that there is hardly a chance to keep their patient’s condition stable until heart transplant becomes possible. Waiting times are much too long until donor hearts become available. The demand for life-saving heart assist devices, which could bridge the time by mechanically supporting the heart function, is enormous. But the therapy option with a so-called „Ventricular Assist Device“ (VAD) is not yet established, nor is reimbursement for those critically ill patients clarified. First achievements with the EXCOR® Pediatric device turned out with great success. Prof. J. Skalski, leading heart surgeon at the University hospital in Krakow, implanted end of 2009 the EXCOR® Pediatric device from Berlin Heart to a 1 year-old girl. The operation itself and also the post-operative time went perfect, meanwhile the girl has been transplanted. As Poland’s second recipient a 7 year-old boy received the heart assist device just two weeks ago in Zabrze. Also in his case the operation went without complications. A doctor from Krakow, who already attended the first implantation, came to support his colleagues during the operation. Medical and technical support was also provided by Berlin Heart specialists from Germany, who were on site during and also after the implantations in order to train staff on system handling and patient management. „We hope that those two success stories are helping to establish VAD therapy as an official option in Poland for these critically ill patients“, says Dr. Stefan Thamasett, General Manager of Berlin Heart. „Both clinics show the necessary pre-requisites. Prof. J. Skalski and his team are one of Poland’s most experienced heart centres. In Zabrze the clinic has just opened, medical and technical equipment is highly professional, perfect for setting up a VAD program.“

About EXCOR®
EXCOR® is a para-corporeal ventricular assist device for patients of all age groups, from newborns to adults. It is used for short-, mid- and long-term cardiac support and can support failing hearts for any duration from a couple of days to several months and years. Since the first implantation in 1988 EXCOR® has been implanted in more than 2.000 patients worldwide.

EXCOR® is currently under clinical investigation for paediatric use in USA. All other products are not FDA approved.

About Berlin Heart
Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices for patients of every age and body size. The company is the market leader in Germany and Europe.

Berlin Heart GmbH
Wiesenweg 10
12247 Berlin

www.berlinheart.de
info@berlinheart.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hope for a new possibility of therapy for children suffering from heart insufficiency in Poland - First EXCOR® Pediatric implantations successful here

News-ID: 177348 • Views:

More Releases from Berlin Heart

100th EXCOR® Implantation in Spain
100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed. The clinics in Spain benefit from an excellent service by Palex Medical
The 1,500th child supported by the Berlin Heart ventricular assist device has been transplanted
The 1,500th child supported by the Berlin Heart ventricular assist device has be …
The EXCOR® Pediatric ventricular assist device (VAD) has been implanted in more than 1,500 children worldwide to save their lives. In June 2014 for the 1,500th time, the EXCOR® Pediatric device was implanted to save the life of a child: a 14-year-old boy from Hong Kong who was suffering from dilated cardiomyopathy since the age of four was supported with the life-saving device. Up to that point the teenager had

More Releases for EXCOR®

100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed. The clinics in Spain benefit from an excellent service by Palex Medical
1. Japanese EXCOR® Pediatric patient successfully transplanted
Berlin, 19.06.2013: The wait for a donor heart is over for the 1st Japanese patient treated with the EXCOR® Pediatric. On May 20th, 2013 the two-year-old girl was successfully transplanted at Morgan Stanley Childrens Hospital, New York Columbia Presbyterian Medical Center. According to the patient’s physicians, she tolerated the procedure well and is recovering as expected. In August 2012, for the first time in Japan’s history, it was possible
Longest support time with the EXCOR® Pediatric ventricular assist device
Six year old Lara from Erlangen is the toddler with the longest support time of a ventricular assist device (VAD) in the world. The small patient was treated an entire 877 days with the VAD EXCOR® Pediatric in the University Hospital in Erlangen and, thanks to this therapy, could recover so well that she was now able to receive a new heart a few days ago. In February 2010 Lara was in
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007, is the first prospective clinical
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
Berlin Germany 12 April 2011: The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007,
Successful transatlantic EXCOR® air ambulance transportations
Berlin, 30 March 2011. Four young children suffering from severe heart failure and consequently supported by the EXCOR® ventricular assist device, were safely and successfully transported by aircraft during the last months. The so-called artificial heart was implanted in order to assist the patient’s heart function of pumping blood through the body. As a life-saving device, it bridges the time until a donor heart is found and transplantation becomes possible.